Stay updated on Brexanolone in COVID-19 ARDS Clinical Trial
Sign up to get notified when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.

Latest updates to the Brexanolone in COVID-19 ARDS Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision label on the page was updated from v3.5.3 to v3.5.4, indicating an administrative update to the page’s version history rather than changes to the study details.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page’s revision/version number was updated from v3.5.2 to v3.5.3, indicating a change to the ClinicalTrials.gov site release rather than any study detail.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page revision tag was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no impact on study data or user-facing content.SummaryDifference0.1%

- Check103 days agoChange DetectedAdded a new site revision entry Revision: v3.4.2. Removed the notification about government funding lapses and the earlier Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Brexanolone in COVID-19 ARDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.